Skip to content

Comparison of EUS-FNB Biopsy Techniques of Solid Pancreatic Lesions

Comparación de Tres técnicas de Biopsia Guiada Por Endosonografia de Lesiones sólidas pancreáticas

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04843956
Enrollment
41
Registered
2021-04-14
Start date
2020-01-08
Completion date
2021-04-30
Last updated
2021-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Neoplasm

Brief summary

Patients with a diagnosis of solid pancreatic lesions evidenced by imaging studies (CT, MRI) and who undergo endoscopic ultrasound-guided biopsy will be selected. Biopsies will be taken using modified tip needles (FNB) three different methods (capillary by suction, capillary without suction and wet suction). From the results obtained from the pathology service, 3 variables will be assessed; Cellularity, blood contamination and suitability for a diagnosis.

Detailed description

EUS-BAAF procedure The procedure will be performed with a linear echoendoscope (PENTAX 3.8 EG-3870 UTK) and a HITACHI HI VISION Avius ultrasound processor, after deep sedation by the anesthesiology service. BAF Acquire # 22 needles (Boston Scientific, Malborough, MA) will be used. 3 passes will be made to the tumor, each pass will consist of 10-15 movements of the needle back and forth in a fan within the solid lesion, under complete ultrasound control (ESGE 2017- Gastrointest Endoscopy Clin N Am 22 (2012) 155 -167). Doppler will be used to avoid any vascular structure in the path of the needle. The passes will be in three different ways to compare. 1. Capillary with suction (puncture with gradual withdrawal of the stylet, applying dry suction with a 10 ml air vacuum syringe after removing the stylet) 2. Capillary without suction (puncture with removal of the stylet gradually, without suction after removing the stylet) 3. Moist suction (Before the puncture, the stylet is removed from the needle and irrigated with 1-2 ml saline solution to replace the air column with liquid, then the solid lesion is punctured and suction is placed with a vacuum syringe of 10 ml of air) The quality of the biopsy will be evaluated by the pathologist independently and without knowing how the sample was obtained.

Interventions

DIAGNOSTIC_TESTEndoscopic ultrasound-guided biopsy

Capillary with suction (puncture with gradual withdrawal of the stylet, applying dry suction with a 10 ml air vacuum syringe after removing the stylet) Capillary without suction (puncture with removal of the stylet gradually, without suction after removing the stylet) wet suction (Prior to puncture, the stylet is removed from the needle and irrigated with 1-2 ml saline solution to replace the air column with liquid, then the solid lesion is punctured and suction is placed with a 10 ml vacuum syringe of air)

Sponsors

Hospital Universitario Dr. Jose E. Gonzalez
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Masking description

The samples will be analyzed independently by the pathology service, not knowing the order and the technique in which the samples were obtained. The histopathological result will be immediately available for patient care, however, the score obtained regarding the quality of the sample will correlate with the technique and the number of passes until the n of the study is completed.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Over 18 years old * Any gender. * Patients with solid pancreatic lesions evidenced by CT or MRI who do not have a histopathological diagnosis.

Exclusion criteria

* That no lesion in the pancreas is identified by EUS. * Pancreatic lesions with a cystic component. * Alteration of coagulation parameters (INR\> 1.5, Platelets \<50,000 / mm3) or having taken antiplatelet agents or oral anticoagulants one week prior to the biopsy. * History of acute pancreatitis in the last 4 weeks. * Pregnant * Refusal or inability to sign informed consent

Design outcomes

Primary

MeasureTime frameDescription
Quality of the sample in relation to the technique18 monthsEstablish if there is a difference in the quality of the sample in relation to the technique used to obtain it

Secondary

MeasureTime frameDescription
Sample contamination relative to technique18 monthsEstablish if there is a difference in the contamination of the sample, in relation to the technique used to obtain it

Countries

Mexico

Contacts

Primary ContactHector Miguel Delgado Cortes, M.D
hectorm.delgado@gmail.com+524423395099
Backup ContactJoel Omar Jaquez Quintana
jomjaqui@hotmail.com+528114183484

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026